Shares of Nobilis Health Corp (NYSE:HLTH) have earned an average broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy rating.

Brokerages have set a 12-month consensus price objective of $5.25 for the company and are expecting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also given Nobilis Health Corp an industry rank of 70 out of 265 based on the ratings given to related companies.

A number of brokerages have weighed in on HLTH. Canaccord Genuity set a $4.80 target price on Nobilis Health Corp and gave the stock a “buy” rating in a research note on Monday. Zacks Investment Research raised Nobilis Health Corp from a “hold” rating to a “buy” rating and set a $3.50 price objective for the company in a report on Monday, August 22nd.

Institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its position in Nobilis Health Corp by 10.4% in the first quarter. Geode Capital Management LLC now owns 34,596 shares of the company’s stock worth $108,000 after buying an additional 3,268 shares in the last quarter. Royal Bank of Canada boosted its position in Nobilis Health Corp by 27.1% in the first quarter. Royal Bank of Canada now owns 36,858 shares of the company’s stock worth $115,000 after buying an additional 7,854 shares in the last quarter. Rhumbline Advisers boosted its position in Nobilis Health Corp by 88.6% in the second quarter. Rhumbline Advisers now owns 44,997 shares of the company’s stock worth $100,000 after buying an additional 21,135 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Nobilis Health Corp by 151.7% in the first quarter. Goldman Sachs Group Inc. now owns 56,894 shares of the company’s stock worth $178,000 after buying an additional 34,288 shares in the last quarter. Finally, Acadian Asset Management LLC bought a new position in Nobilis Health Corp during the second quarter worth approximately $165,000.

Shares of Nobilis Health Corp (NYSE:HLTH) traded down 1.76% during trading on Tuesday, hitting $3.35. 120,551 shares of the stock were exchanged. Nobilis Health Corp has a 52 week low of $1.82 and a 52 week high of $5.95. The stock’s 50 day moving average price is $3.22 and its 200 day moving average price is $3.10. The firm has a market capitalization of $257.22 million and a price-to-earnings ratio of 4.92.

Nobilis Health Corp (NYSE:HLTH) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.05. The firm earned $61.90 million during the quarter, compared to the consensus estimate of $62.18 million. The company’s revenue for the quarter was up 26.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.02) EPS. On average, equities analysts predict that Nobilis Health Corp will post $0.32 earnings per share for the current year.

Nobilis Health Corp Company Profile

Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.

5 Day Chart for NYSE:HLTH

Get a free copy of the Zacks research report on Nobilis Health Corp (HLTH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nobilis Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.